| Date & Time | 26 January 2024 |
|---|---|
| Location | Online |
Marc Van Dijk (UCB) and Luis Pinheiro (EMA) will present views of industry and regulators on various facets of collecting, processing, and using data for research, regulatory and healthcare decisions. The two keynote talks will provide an overview of patient needs and challenges in rare disease R&D and of data and technologies that offer solutions to those challenges.
The panel discussion between representatives of patients, academia, regulatory scientists, industry and clinicians and with the audience will provide different perspectives on challenges and solutions in the context of regulatory realities and imperatives. They will also provide examples of solutions already used and their limitations.
During this webinar panelists and participants will discuss:
- How to plan for the data needs for the future of medicine development for rare diseases.
- How to anticipate the scope, depth, and quality of data that will be required to generate reliable evidence suitable for regulatory use cases.
- The tools that are available to make data collection accessible for these uses.
Learn more and register here.
